Technical Analysis for CSBR - Champions Oncology, Inc.

Grade Last Price % Change Price Change
grade F 8.5 -4.06% -0.36
CSBR closed down 4.06 percent on Friday, May 17, 2019, on 38 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical CSBR trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
MACD Bearish Signal Line Cross Bearish 0.00%
180 Bearish Setup Bearish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -4.06%
Crossed Above 20 DMA Bullish -4.06%
MACD Bullish Signal Line Cross Bullish -4.06%
Bollinger Band Squeeze Range Contraction -4.06%

Older signals for CSBR ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides Personalized Oncology Solutions (POS) that assists physicians in developing personalized treatment options for cancer patients through tumor specific data obtained from drug panels and related personalized oncology services. It also offers POS products, including personalized tumor boards that are designed to provide access to oncologists with expertise in particular tumor types; and gene sequencing that analyzes the genetic makeup of patient's tumor for the purpose of identifying useful drugs. In addition, the company offers Translational Oncology Solutions (TOS), including a preclinical Tumorgraft platform to pharmaceutical and biotechnology companies that uses vivo studies, which rely on implanting multiple tumors from TumorBank in mice and testing the therapy of interest on tumors. Further, it provides a bank of tumors that are acquired, collected, processed, validated, and stored for the use in TOS. The company markets its products through Internet, word of mouth, and a network of sales force. It serves patients, physicians, and drug development companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011 to reflect its new focus on developing technologies to personalize the development and use of oncology drugs. Champions Oncology, Inc. is headquartered in Hackensack, New Jersey.
Bank Biotechnology Health Cancer Technology Solutions Tumor Drug Development Tumors Cancer Care Basilea Pharmaceutica Patient's Tumor
Is CSBR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 17.9
52 Week Low 3.92
Average Volume 43,120
200-Day Moving Average 10.1607
50-Day Moving Average 9.1357
20-Day Moving Average 8.7651
10-Day Moving Average 8.795
Average True Range 0.5185
ADX 18.08
+DI 15.3589
-DI 19.6033
Chandelier Exit (Long, 3 ATRs ) 7.8445
Chandelier Exit (Short, 3 ATRs ) 8.8955
Upper Bollinger Band 9.379
Lower Bollinger Band 8.1512
Percent B (%b) 0.28
BandWidth 14.007826
MACD Line -0.0995
MACD Signal Line -0.0964
MACD Histogram -0.0031
Fundamentals Value
Market Cap 93.37 Million
Num Shares 11 Million
EPS -0.46
Price-to-Earnings (P/E) Ratio -18.48
Price-to-Sales 2.13
Price-to-Book 125.38
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.10
Resistance 3 (R3) 9.16 9.02 9.00
Resistance 2 (R2) 9.02 8.87 8.99 8.97
Resistance 1 (R1) 8.76 8.77 8.69 8.70 8.93
Pivot Point 8.62 8.62 8.59 8.59 8.62
Support 1 (S1) 8.36 8.47 8.29 8.30 8.07
Support 2 (S2) 8.22 8.37 8.19 8.03
Support 3 (S3) 7.96 8.22 8.00
Support 4 (S4) 7.90